GeneDx Holdings Corp. (WGS)

NASDAQ: WGS · USD

$64.7

+1.91 (+3.0%)· Recorded snapshot

Market cap	1.9B
Revenue (ttm)	454.4M
Net income (ttm)	-106.4M
EPS (ttm)	-$3.64
Shares out	29.8M
P/E (forward)	98.2x
Volume	436,314
Beta	1.97

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 454.4M
Net income (ttm): -106.4M
EPS (ttm): -$3.64
P/E (forward): 98.2x
Market cap: 1.9B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E98.2

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-40.8

P25 n/aP50 n/aP75 n/a

ROIC-22.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All WGS indicators

Market & fundamental data

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001818331
Company name	GeneDx Holdings Corp.
Country	United States
Country code	US
CUSIP number	81663L200
Earnings date	2026-11-09
Earnings time	amc
Employees	1,300
Employees change	300
Employees growth	30%
Enterprise value	$2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
In index	RUSSELL2000
Industry	Diagnostics & Research
Is primary listing	Yes
Is SPAC	No
ISIN number	US81663L2007
Last 10-K release date	2026-02-23
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split date	2023-05-04
Last stock split type	Reverse
Market cap	$1.9B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$64.66
Price currency	USD
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-28
Symbol	WGS
U.S. state	Connecticut
Website	https://www.genedx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	179.6x
Earnings yield	-5.63%
EV/Sales	4.41x
FCF / EV yield	-3.79%
FCF yield	-3.85%
Forward EV/Sales	3.71x
Forward P/E	98.16x
Forward P/S	3.65x
Industry forward P/E	30.87x
Industry P/E	50.24x
P/B ratio	7.66x
P/S ratio	4.33x
Price / tangible book value	19.43x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-13.13%
EBITDA margin	-7.41%
Gross margin	69.38%
Operating margin	-13.13%
Pretax margin	-23.39%
Profit margin	-23.4%
Profit per employee	$-81,813
Revenue per employee	$349,558
ROA	-7.89%
ROA (5Y)	-30.46%
ROCE	-14.67%
ROE	-40.8%
ROE (5Y)	-79.76%
ROIC	-22.49%
SBC / revenue	7.86%
Tax / revenue	0.01%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	6
Gross profit growth	29.53%
Gross profit growth (Q)	10.41%
Gross profit growth 3Y	116.68%
Gross profit growth 5Y	88.08%
Net income growth years	3
Revenue growth	25.42%
Revenue growth (Q)	11.44%
Revenue growth (QoQ)	11.92%
Revenue growth 3Y	24.33%
Revenue growth 5Y	16.28%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-27.1M
Depreciation and amortization	$26M
EBIT	$-59.7M
EBITDA	$-33.7M
EPS	$-3.64
FCF per share	$-2.54
Financing cash flow	$73.6M
Free cash flow	$-75.8M
Free cash flow minus SBC	$-111.5M
Gross profit	$315.3M
Income taxes	$62,000
Investing cash flow	$-38.6M
Net borrowing	$35.4M
Net cash flow	$-13.8M
Net income	$-106.4M
Operating cash flow minus SBC	$-84.4M
Operating income	$-59.7M
Revenue	$454.4M
Stock-based compensation	$35.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.98
Book value per share	$8.19
Debt / equity	0.69
Goodwill	$1.6M
Interest coverage	-20
Long-term assets	$235.1M
Long-term liabilities	$162.6M
Net cash (debt)	$-34.9M
Net cash / market cap	-1.77%
Net debt / equity	0.14
Piotroski F-Score	4
Property, plant and equipment	$87.9M
Shareholders' equity	$244.2M
Tangible book value	$101.2M
Tangible book value per share	$3.40
Total assets	$481.5M
Total cash	$132.5M
Total debt	$167.4M
Total liabilities	$237.3M
WACC	14.01%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.96
Current assets	$246.4M
Current liabilities	$74.6M
Current ratio	3.3
Inventory turnover	9.35
Net working capital	$44.9M
Quick ratio	2.9
Working capital	$171.7M
Working capital turnover	2.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.38%
Dividend yield	0%
Shareholder yield	-2.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$67.12
1D price change	3.05%
1M price change	-25.94%
1M total return	-25.94%
1W price change	-4.76%
1W total return	-4.76%
1Y price change	-49.89%
1Y return CAGR	-49.92%
1Y total return	-49.89%
20-day SMA	$67.17
200-day SMA	$72.30
3M price change	8.14%
3M total return	8.14%
3Y price change	2,142.12%
3Y return CAGR	181.91%
3Y total return	2,142.12%
50-day SMA	$79.50
50-day SMA vs 200-day SMA	50over200
52-week high	$170.87
52-week high date	2025-12-02
52-week low	$32.21
52-week low date	2026-05-06
5Y price change	-74.6%
5Y return CAGR	-23.97%
5Y total return	-74.6%
6M price change	-1.06%
6M total return	-1.06%
All-time high	$896.94
All-time high date	2021-02-12
All-time low	$1.16
All-time low date	2023-11-16
Average true range (ATR)	$5.75
Average volume	790.1K
Beta (1Y)	0.81
Beta (2Y)	0.95
Beta (5Y)	1.97
Change from 52-week high	-62.16%
Change from 52-week low	100.73%
Change from all-time high	-92.7%
Change from all-time low	5,543.97%
Change from open	0.41%
Day's gap	2.63%
Dollar volume	$28.2M
High price	$67.27
Low price	$64.39
Monthly RSI	46.53
Open price	$64.39
Position in 52-week range	9.2%
Premarket change	1.02%
Premarket close	$62.74
Premarket price	$63.38
Premarket volume	252
Previous close	$62.74
Price vs 150-day SMA	-2.46%
Price vs 20-day SMA	-2.53%
Price vs 200-day SMA	-9.45%
Price vs 50-day SMA	-17.65%
Relative volume	0.55
RSI	44.16
Sharpe ratio	-0.32
Sharpe ratio (3Y)	1.43
Sharpe ratio (5Y)	0.26
Sortino ratio	-0.34
Sortino ratio (3Y)	2.43
Sortino ratio (5Y)	0.46
Volume	436.3K
Weekly RSI	45
YTD price change	-49.66%
YTD total return	-49.66%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20.4M
Float percentage	68.55%
Shares change (QoQ)	1.28%
Shares change (YoY)	2.38%
Shares held by insiders	1.86%
Shares held by institutions	82.34%
Shares outstanding	29.8M
Short % of float	27.52%
Short % of shares	18.87%
Short ratio	7.7 days

Deeper analysis on WGS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this WGS report

Is a complete WGS research report available?

No complete published report is available for GeneDx Holdings Corp. (WGS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

GeneDx Holdings Corp. (WGS)

Price

Financial snapshot

Fair-value bridge

Latest news · WGS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All WGS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on WGS

Frequently asked questions